Le Lézard
Classified in: Health, Business
Subject: CXP

NYC Dermatologist Bobby Buka Adds Fifth Location

NEW YORK, July 6, 2016 /PRNewswire/ -- Dr. Bobby Buka and his team are happy to announce the opening of their fifth location in Crown Heights, NY. The new office, located at 614 Eastern Parkway in Brooklyn, is a convenient destination for their loyal and growing patient base. The Crown Heights location is now accepting appointments for July 2016.

Crown Heights is a neighborhood located in the central portion of New York City, bordered by four historic districts. This neighborhood was also one of the most affluent neighborhoods in Brooklyn between 1890 and 1910.

The Crown Heights office conveniently offers ample street parking alongside the office and is located next to multiple MTA stops. These include: the "3" train at Nostrand and Kingston Ave; and the "2" or "5" train at President or Sterling Street. Once patients come in for their dermatology appointment, they will be greeted by friendly office staff and see their board-certified dermatologist of choice for medical or cosmetic consultations and treatments.

Voted "Best Dermatologist NYC," Bobby Buka MD provides medical and beauty solutions for patients seeking skin health and perfection. From treating acne and skin conditions to reversing the signs of aging, Dr. Buka and his team provide the highest quality care in dermatology services.

Beauty services include the popular brand name, Botox®, dermal fillers, laser skin resurfacing, and the new uplifting ultrasound treatment, Ultherapy®. Medical services include professional wart removal, skin cancer prevention and treatments for various skin conditions, such as psoriasis, rosacea, eczema, and acne. A full list of services are provided on his website (bobbybukamd.com).

"We're very excited about our expansion into an underserved, thriving area of Brooklyn. The Crown Heights community has been exceptionally gracious in welcoming us to the neighborhood. That's important to us because, at the end of the day, we're still just a neighborhood practice with a national reputation," said Dr. Bobby Buka.

Dr. Buka is a graduate of the Feinberg School of Medicine at Northwestern University in Chicago. After his internship in internal medicine at Saint Vincent's Hospital in New York City, he completed a dermatology residency at the University of California, and a fellowship in pediatric dermatology at Children's Hospital in San Diego. Dr. Buka is a member of the American Academy of Dermatology and has hospital affiliations with Mount Sinai Hospital.

Dr. Buka also invites everyone to visit his website to learn more about his qualifications, hospital affiliations, and clinical awards for excellence in the field of dermatology. Website visitors can also schedule and register for appointments, read recent articles, as well as learn about their skin condition with a patient education section. See why Dr. Bobby Buka is described by NBC NonStop as, "New York City's most sought after dermatologist."

For more information or to book your consultation at the new Crown Heights or existing locations, please visit www.bobbybukamd.com or call at (212) 385-3700.

SOURCE Bobby Buka MD

These press releases may also interest you

at 07:55
Pfizer Inc. today announced important advances in the battle against the global COVID-19 pandemic. As outlined in Pfizer's five-point plan, the company has been collaborating across the healthcare innovation ecosystem ranging from large...

at 07:55
BioNTech SE , and Pfizer Inc. today disclosed additional details of their collaboration to advance candidates from BioNTech's mRNA vaccine program, previously announced on March 17, 2020. The collaboration aims to rapidly advance multiple COVID-19...

at 07:45
The "Global Autoimmune Partnering 2014-2020: Deal Trends, Players and Financials" report has been added to ResearchAndMarkets.com's offering. Global Autoimmune Partnering 2014 to 2020 provides the full collection of Autoimmune disease deals signed...

at 07:40
The "Global Dermatology Partnering 2014-2020: Deal Trends, Players and Financials" report has been added to ResearchAndMarkets.com's offering. This report provides an understanding and access to the dermatology partnering deals and agreements...

at 07:35
Scholar Rock , a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, today announced that the United States Patent Office (USPTO) issued U.S. Patent No....

at 07:35
ReForm Biologics, a pharmaceutical technology company developing innovative biologic formulations to improve drug delivery and manufacturing, expanded its patent portfolio with the issuance of U.S. Patent No. 10,610,600 and its first patent in Japan,...

News published on 6 july 2016 at 11:23 and distributed by: